| Document Date: 2011-06-09 06:20:31
Open Document File Size: 467,01 KBShare Result on Facebook
City Plendil / Supplementary Information Felodipine / Treatments Felodipine / Felodipine / / Company BP / Paediatric Working Group / Sanofi / Simesa Management / AstraZeneca / / Country United States / United Kingdom / Denmark / / Facility Description Trail / / IndustryTerm pharmaceutical formulation / authorised medicinal products / tablets/solution / age / medicinal product / medicinal products / food / / MedicalCondition secondary hypertension / congestive heart failure / renal artery stenosis / hypertension / primary hypertension / disease / D Description Renal disease / seizures / Hypertension Hypertension / Renal parenchymal and renovascular diseases / renal artery thrombosis / paediatric hypertension / CMD / Primary (essential) hypertension / hypertensive encephalopathy / angina pectoris / renal parenchymal disease / chronic stable angina pectoris / renal and renovascular diseases / renal disease / childhood obesity / renal parenchymal and structural renal disease / / MusicGroup A Group / / Organization Committee on Safety / MHRA / US food and drug administration / Clinical Research Unit / European Union / Committee on Safety of Medicines / / Position EXECUTIVE / / Product Prolonged / C08CA02 Modified-release tablet / Felodipine / / Technology pharmacokinetics / CVD / /
SocialTag |
Microsoft Word - Felodipine_2009 11_45PaedPAR.doc